Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000783

Drug Information
NameMycophenolate mofetil
SynonymsCHEMBL1456; TM-MMF; NCGC00159459-02; C23H31NO7; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); o-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-; ME-MPA; NCGC00159459-03; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate; S1501_Selleck; 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-; C07908; Mycophenylate mofetil; 128794-94-5; CellCept; I01-0898; AR-1J6939; LS-75572; 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)-; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; RS 61443; 140401-05-4; Cellcept (TN); RS-61443; RS-61443-190; AC1NQXZW; AC1Q6O6X; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 115007-34-6; HSDB 7436; Mycophenolic acid morpholinoethyl ester; BB_NC-2566; LS-172272; 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; mycophenolate mofetil; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; UNII-9242ECW6R0; 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CID5281078; I06-1947; R-99; MMF; TL8000648; DB00688; HMS2090A03; AC-1562; MolPort-000-883-800; NSC724229; ZINC21297660; D00752
Trade NameCellCept
IndicationOrgan transplant rejection
[ICD9: 279.5, 996   ICD10: D89.8, T86]
Approved    [1]
Pemphigus vulgaris
[ICD9: 694.4   ICD10: L10.0]
Phase III    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassImmunosuppressive Agents
CAS NumberCAS 128794-94-5
PubChem Compound IDCID 5281078.
PubChem Substance IDSID 10110.
SuperDrug ATC IDL04AA06
TargetInosine-5'-monophosphate dehydrogenase 2Inhibitor[2]
Inosine-5'-monophosphate dehydrogenase 2Inhibitor[3][4]
Ref 1Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54. To Reference
Ref 2Roche. Product Development Pipeline. July 29 2009. To Reference
Ref 3Clin Chem. 2009 May;55(5):986-93. Epub 2009 Mar 19.Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase. To Reference
Ref 4Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543